Sleep TMS for Depression (NCT06824415)

🧪 Interventions in This Study

• TMS (DEVICE)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• Stanford University — Stanford, California

📞 Contact the Study Coordinator

Phone: (408) 909-2203

Email: kellerlab@stanford.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Major Depression

• Study of Psilocybin Under Anesthesia Controlled by EEG — Stanford, California
• Synaptic Mechanisms of Intermittent Theta Burst Stimulation for Major Depressive Disorder — Belmont, Massachusetts
• Single Day of Ultra-accelerated TMS With a Single Dose of NRX-101 — Belmont, Massachusetts
• Leucine in Midlife Depression — Atlanta, Georgia
• Characterizing Cognitive Decline in Late Life Depression: The ADNI Depression Project — San Francisco, California
• Synaptic Mechanisms of Continuous Theta Burst Stimulation in Depression — Belmont, Massachusetts

Explore by condition: All Major Depression clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.